CD4 and myeloid sarcoma: To further characterize the CNS infiltrating CD4+ T cells, we measured in a non-exclusive manner the expression of Th1 and Th17 signature cytokines IFN-γ and IL-17, respectively, in addition to GM-CSF, which has been proposed as a pathogenic mediator in MS and EAE (46–49).